AAAAAA

   
Results: 1-7 |
Results: 7

Authors: Tognoni, A Pensa, F Vaira, F Vigani, A Bancalari, L Fiasella, L Maggiani, R Canessa, P Pronzato, P
Citation: A. Tognoni et al., A three-drug regimen (gemcitabine, ifosfamide and cisplatin) for advanced non-small-cell lung cancer, J CHEMOTHER, 13(2), 2001, pp. 202-205

Authors: Del Mastro, L Venturini, M Lionetto, R Carnino, F Guarneri, D Gallo, L Contu, A Pronzato, P Vesentini, L Bergaglio, M Comis, S Rosso, R
Citation: L. Del Mastro et al., Accelerated-intensified cyclophosphamide, epirubicin, and fluorouracil (CEF) compared with standard CEF in metastatic breast cancer patients: Resultsof a multicenter, randomized phase III study of the Italian Gruppo Oncologico Nord-Ouest-Mammella Inter Gruppo Group, J CL ONCOL, 19(8), 2001, pp. 2213-2221

Authors: Pronzato, P Queirolo, P Vecchio, S Lionetto, R Del Mastro, L Venturini, M Gardin, G Alama, A Sertoli, MR
Citation: P. Pronzato et al., Thymidine labeling index analysis in early breast cancer patients randomized to receive perioperative chemotherapy, ONCOL-BASEL, 60(1), 2001, pp. 88-93

Authors: Tognoni, A Pronzato, P Cadenotti, L Ghio, E Manna, N Pensa, F Marino, L
Citation: A. Tognoni et al., Sequential high dose-density chemotherapy in advanced ovarian cancer, ANTICANC R, 20(5C), 2000, pp. 3957-3961

Authors: Vigani, A Pensa, F Vaira, F Bancalari, L Cordani, S Maggiani, R Canessa, P Pronzato, P
Citation: A. Vigani et al., Sequential high dose-density chemotherapy with two active regimens for advanced small cell lung cancer., ANTICANC R, 20(5C), 2000, pp. 4015-4018

Authors: Venturino, A Comandini, D Simoni, C Merlini, L Naso, C Palumbo, R Fusco, V Porcile, G Pronzato, P Rosso, R Repetto, L
Citation: A. Venturino et al., Is salvage chemotherapy for metastatic breast cancer always effective and well tolerated? A phase II randomized trial of vinorelbine versus 5-fluorouracil plus leucovorin versus combination of mitoxantrone, 5-fluorouracil plus leucovorin, BREAST CANC, 60(3), 2000, pp. 195-200

Authors: Tognoni, A Cadenotti, L Pensa, F Vaira, F Vigani, A Bancalari, L Cordani, S Maggiani, R Canessa, PA Pronzato, P
Citation: A. Tognoni et al., A phase II study of a three-drug combination (cisplatin, ifosfamide and vinorelbine) plus granulocyte-colony stimulating factor in advanced non smallcell lung cancer, J CHEMOTHER, 11(4), 1999, pp. 306-309
Risultati: 1-7 |